Sio Capital Management LLC's Q1 2023 13F: 17 new positions, 14 exits

Form 13F-HR for the quarter ended Mar 31, 2023 · filed May 12, 2023 · 44 reported positions · accession 0001214659-23-006952

What changed this quarter

Sio Capital Management LLC's changes in reported equity positions, Q1 2023
Activity Security Weight before Weight now Change Shares Shares %
New CENTENE CORP DEL (CNC) — 13.5% +13.5 pts +433K sh new
Exited MEDICUS SCIENCES ACQUISITION (MSAC) 12.5% — −12.5 pts −2.32M sh −100%
New GE HEALTHCARE TECHNOLOGIES INC (GEHC) — 8.0% +8.0 pts +197K sh new
Increased CIGNA GROUP (CI) 9.3% 11.0% +1.7 pts +34,564 sh +66%
Exited STAAR SURGICAL CO (STAA) 4.1% — −4.1 pts −157K sh −100%
Exited ICON PLC (ICLR) 3.5% — −3.5 pts −33,983 sh −100%
Increased AMERISOURCEBERGEN CORP (COR) 7.5% 10.1% +2.7 pts +43,765 sh +52%
Reduced HESKA CORP (HSKA) 2.8% 0.8% −2.0 pts −66,859 sh −79%
Increased BICYCLE THERAPEUTICS PLC (BCYC) 10.8% 10.2% −0.6 pts +284K sh +42%
Exited PROTAGONIST THERAPEUTICS INC (PTGX) 2.5% — −2.5 pts −435K sh −100%
Increased UNITED THERAPEUTICS CORP (UTHR) 8.1% 8.3% +0.2 pts +20,044 sh +36%
New ADC THERAPEUTICS SA (ADCT) — 2.1% +2.1 pts +2.16M sh new
New VIKING THERAPEUTICS INC (VKTX) — 2.1% +2.1 pts +250K sh new
New AXONICS INC (AXNX) — 1.9% +1.9 pts +70,841 sh new
New GLOBUS MEDICAL INC (GMED) — 1.9% +1.9 pts +67,500 sh new
New RELAY THERAPEUTICS INC (RLAY) — 1.9% +1.9 pts +230K sh new
Exited NOVAVAX INC (NVAX) 1.9% — −1.9 pts −340K sh −100%
Exited CYMABAY THERAPEUTICS INC (CBAY) 1.9% — −1.9 pts −556K sh −100%
Reduced MEDTRONIC PLC (MDT) 5.3% 3.3% −2.0 pts −43,988 sh −34%
Reduced ORGANON & CO (OGN) 8.8% 5.5% −3.3 pts −116K sh −20%
New REVOLUTION MEDICINES INC (RVMD) — 1.3% +1.3 pts +126K sh new
Exited HEALTH SCIENCES ACQUISITIONS CORP 2 (HSAQ) 1.3% — −1.3 pts −250K sh −100%
New REPARE THERAPEUTICS INC (RPTX) — 1.1% +1.1 pts +229K sh new
Reduced INOGEN INC (INGN) 3.0% 0.7% −2.3 pts −165K sh −58%
Exited X4 PHARMACEUTICALS INC (XFOR) 1.0% — −1.0 pts −1.83M sh −100%
New CENTESSA PHARMACEUTICALS PLC (CNTA) — 0.7% +0.7 pts +348K sh new
Reduced MERUS NV (MRUS) 0.7% 0.1% −0.6 pts −72,389 sh −82%
Increased NYXOAH SA (NYXH) 0.0% 0.7% +0.7 pts +173K sh +1072%
Exited TYRA BIOSCIENCES INC (TYRA) 0.6% — −0.6 pts −152K sh −100%
New APREA THERAPEUTICS INC (APRE) — 0.6% +0.6 pts +280K sh new
New CORBUS PHARMACEUTICALS HOLDINGS (CRBP) — 0.5% +0.5 pts +150K sh new
Increased ELEVATION ONCOLOGY INC (ELEV) 0.2% 0.8% +0.6 pts +517K sh +144%
Exited RELMADA THERAPEUTICS INC (RLMD) 0.4% — −0.4 pts −236K sh −100%
Increased CTI BIOPHARMA CORP (CTIC) 1.1% 1.1% 0.0 pts +196K sh +59%
Increased AVANTOR INC (AVTR) 2.8% 3.0% +0.1 pts +33,136 sh +13%
New NEOVASC INC (NVCN) — 0.3% +0.3 pts +22,537 sh new
Exited CONNECT BIOPHARMA HOLDINGS LTD (CNTB) 0.3% — −0.3 pts −598K sh −100%
Exited SIENTRA INC (SIEN) 0.3% — −0.3 pts −2.55M sh −100%
Reduced PHARVARIS NV (PHVS) 1.7% 0.9% −0.8 pts −56,615 sh −20%
New SIENTRA INC (SIENQ) — 0.2% +0.2 pts +255K sh new
Increased MERRIMACK PHARMACEUTICALS INC (MACK) 1.5% 1.7% +0.1 pts +22,843 sh +9%
Increased SAVARA INC (SVRA) 0.7% 0.9% +0.2 pts +82,009 sh +9%
Reduced VANDA PHARMACEUTICALS INC (VNDA) 0.5% 0.4% −0.1 pts −12,528 sh −9%
New ROCKET PHARMACEUTICALS INC (RCKTW) — 0.0% 0.0 pts +400K sh new
Reduced FUSION PHARMACEUTICALS INC (FUSN) 0.4% 0.5% 0.0 pts −14,412 sh −6%
Reduced CAREMAX INC (CMAX) 0.1% 0.0% 0.0 pts −12,808 sh −29%
New HUMACYTE INC (HUMAW) — 0.0% 0.0 pts +49,998 sh new
Reduced MOLECULIN BIOTECH INC (MBRX) 0.6% 0.5% −0.1 pts −25,897 sh −2%
Exited HUMACYTE INC (HUMA) 0.0% — 0.0 pts −49,998 sh −100%
Exited NEOLEUKIN THERAPEUTICS INC (NLTX) 0.0% — 0.0 pts −38,312 sh −100%

The 50 largest of 51 changes, by size of the trade. Full holdings for this quarter.

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:

  • ASLAN PHARMACEUTICALS LTD (ASLN): 04522R101 → 04522R200, 1.27M → 254K shares (share count changed with the identifier; not shown as a trade)

Top 10 positions — 75.0% of the equity book

Changes in the top 10 this quarter: CNC entered · GEHC entered · AVTR entered · ADCT entered · MSAC left · STAA left · ICLR left · INGN left

# Security Weight before Weight now
1 CENTENE CORP DEL (CNC) 0.0% 13.5% Entered the top 10
2 CIGNA GROUP (CI) 9.3% 11.0%
3 BICYCLE THERAPEUTICS PLC (BCYC) 10.8% 10.2%
4 AMERISOURCEBERGEN CORP (COR) 7.5% 10.1%
5 UNITED THERAPEUTICS CORP (UTHR) 8.1% 8.3%
6 GE HEALTHCARE TECHNOLOGIES INC (GEHC) 0.0% 8.0% Entered the top 10
7 ORGANON & CO (OGN) 8.8% 5.5%
8 MEDTRONIC PLC (MDT) 5.3% 3.3%
9 AVANTOR INC (AVTR) 2.8% 3.0% Entered the top 10
10 ADC THERAPEUTICS SA (ADCT) 0.0% 2.1% Entered the top 10
— MEDICUS SCIENCES ACQUISITION (MSAC) 12.5% 0.0% Left the top 10
— STAAR SURGICAL CO (STAA) 4.1% 0.0% Left the top 10
— ICON PLC (ICLR) 3.5% 0.0% Left the top 10
— INOGEN INC (INGN) 3.0% 0.7% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Exited PROMETHEUS BIOSCIENCES INC (RXDX) Put 574K 0 $0
Exited QUEST DIAGNOSTICS INC (DGX) Put 92,000 0 $0
Exited REATA PHARMACEUTICALS INC (RETA) Put 67,000 0 $0
Exited IVERIC BIO INC (ISEE) Put 86,400 0 $0
Exited RELMADA THERAPEUTICS INC (RLMD) Put 236K 0 $0